NCT00370955

Brief Summary

The purpose of this study is to compare two surgical techniques (high vacuum and low vacuum) on corneal endothelium after phacoemulsification.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 1, 2006

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2007

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

December 25, 2009

Status Verified

October 1, 2008

Enrollment Period

5 months

First QC Date

August 31, 2006

Last Update Submit

December 24, 2009

Conditions

Keywords

PhacoemulsificationCorneal endothelial cell lossHydrodynamic parametersTotal ultrasound energyTotal infused fluids

Outcome Measures

Primary Outcomes (1)

  • Total ultrasound energy dissipated to the eye, total infused fluid, Endothelial cell loss

    All patients were examined on postoperative day 1 and weeks 1, 6 and 12.

Study Arms (2)

High vacuum group

ACTIVE COMPARATOR

Those patients who underwent phacoemulsification using high hydrodynamic parameter: 400 mmHg vacuum and 40 ml/min flow rate.

Procedure: phacoemulsification using either high vacuum or low vacuum techniques

Low vacuum group

ACTIVE COMPARATOR

Patients who underwent phacoemulsification using low hydrodynamic parameters: 200 mmHg vacuum and 20 ml/min flow rate.

Procedure: phacoemulsification using either high vacuum or low vacuum techniques

Interventions

All surgeries were performed using Sovereign phacoemulsification system (AMO) using Whitestar technology.

Also known as: stop and chop technique
High vacuum groupLow vacuum group

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Moderate lens opacity (Nuclear sclerosis 3+)
  • Age between 50 to 70 years

You may not qualify if:

  • Previous corneal pathology (dystrophic or degenerative such as Fuchs' endothelial dystrophy or advanced trachoma),
  • Pseudoexfoliation syndrome (PEX),
  • History of intra ocular surgery,
  • Glaucoma or ocular hypertension,
  • Eyes with a history of anterior uveitis,
  • Diabetes mellitus,
  • Anterior chamber depth (ACD) less than 2.5 mm or more than 4 mm,
  • Axial length less than 21 mm or more than 25 mm,
  • Density of endothelial cells less than 1500 cells per mm2,
  • Polymegatism (CV \> 0.4),
  • Keratometric astigmatism more than 1.5 Diopters (D),
  • History of contact lens usage,
  • Intra-operative complications (posterior capsule rupture with or without vitreous loss),
  • Postoperative uveitis,
  • Postoperative surgical wound leakage,
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alireza Baradaran Raffiee

Tehran, Tehran Province, 16666, Iran

Location

Related Links

MeSH Terms

Conditions

CataractCorneal Endothelial Cell Loss

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesCorneal DiseasesEye ManifestationsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Alireza Baradaran Raffiee, MD

    Ophthalmic Research Center of Shaheed Beheshti Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 31, 2006

First Posted

September 1, 2006

Study Start

March 1, 2007

Primary Completion

August 1, 2007

Study Completion

December 1, 2007

Last Updated

December 25, 2009

Record last verified: 2008-10

Locations